Related Experiment Video
Updated: May 9, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice
Vaishya Richa1, Gupta Rahul, Arora Sarika
1Guru Nanak Eye Center, New Delhi, India.
Introduction:
Macroprolactin is a significant cause of misdiagnosis, unnecessary investigation, and inappropriate treatment in patients with hyperprolactinemia. Its frequency has not been clearly established due to technical difficulties in identifying it. Most laboratories and clinicians are unaware of macroprolactin interferences in prolactin assays.
Materials And Methods:
A comprehensive literature search was conducted on the websites of the National Library of Medicine (http://www.ncbl.nlm.nih.gov) and PubMed Central, the US National Library of Medicine's digital archive of life sciences literature (http://www.pubmedcentral.nih.gov/). The data were also looked for in relevant books and journal.
Results:
Macroprolactin is a non-bioactive prolactin isoform usually composed of a prolactin monomer and an IgG molecule having a prolonged clearance rate similar to that of immunoglobulins. This isoform is clinically non-reactive but it interferes with immunological assays used for the detection of prolactin.
Conclusion:
There is a need to understand and explore the recent progress in the diagnosis and pathophysiology of macroprolactinemia for improving patient care.
Insights
Macroprolactin, a non-bioactive form of prolactin, often causes misdiagnosis in hyperprolactinemia patients. Awareness and improved diagnostic methods are crucial for accurate patient care.
Area of Science:
- Endocrinology
- Clinical Chemistry
Background:
- Macroprolactin is a common cause of misdiagnosis and inappropriate treatment in hyperprolactinemia.
- Technical difficulties hinder macroprolactin identification, leading to unawareness among clinicians and labs.
- Interference of macroprolactin in prolactin assays is a significant clinical challenge.
Purpose of the Study:
- To review the current understanding of macroprolactinemia.
- To highlight the diagnostic challenges and clinical implications of macroprolactin.
- To emphasize the need for updated diagnostic and pathophysiological knowledge.
Main Methods:
- A comprehensive literature search was performed.
- Databases searched included PubMed Central and the National Library of Medicine.
- Relevant books and journals were also consulted.
Main Results:
- Macroprolactin is a non-bioactive prolactin isoform, typically a prolactin monomer bound to an IgG molecule.
- It exhibits prolonged clearance, similar to immunoglobulins.
- This isoform is clinically non-reactive but interferes with immunological prolactin assays.
Conclusions:
- There is a critical need to enhance understanding of macroprolactinemia.
- Recent advancements in diagnosis and pathophysiology require exploration.
- Improving patient care necessitates better awareness and diagnostic strategies for macroprolactin.
Related Concept Videos
Hyperthyroidism I: Introduction
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Hyperthyroidism II: Pathophysiology
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Hypothyroidism II: Pathophysiology
Hypoglycemia and Glucagon

